LONG-TERM SAFETY AND EFFICACY OF CANAKINUMAB IN PATIENTS WITH CAPS: FINAL RESULTS FROM THE BETA-CONFIDENT REGISTRY

被引:1
作者
Kuemmerle-Deschner, J. B. [1 ]
Hoffman, H. [2 ]
Hawkins, P. N. [3 ]
van der Poll, T. [4 ]
Walker, U. A. [5 ]
Speziale, A. [6 ]
Tilson, H. H. [7 ]
Joubert, Y. [6 ]
机构
[1] Univ Hosp Tuebingen, Tubingen, Germany
[2] Univ Calif San Diego, La Jolla, CA 92093 USA
[3] UCL, Sch Med, London, England
[4] Univ Amsterdam, Acad Med Ctr, Amsterdam, Netherlands
[5] Univ Hosp, Basel, Switzerland
[6] Novartis Pharma AG, Basel, Switzerland
[7] Univ N Carolina, Chapel Hill, NC USA
关键词
D O I
10.1136/annrheumdis-2016-eular.3827
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
FRI0492
引用
收藏
页码:617 / 617
页数:1
相关论文
共 50 条
  • [21] LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM A SINGLE-CENTER STUDY
    Alexeeva, E.
    Krekhova, E.
    Dvoryakovskaya, T.
    Isaeva, K.
    Chomakhidze, A.
    Chistyakova, E.
    Lomakina, O.
    Denisova, R.
    Mamutova, A.
    Fetisova, A.
    Gautier, M.
    Vankova, D.
    Shingarova, M.
    Kriulin, I.
    Alshevskaya, A.
    Moskalev, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1776 - 1777
  • [22] Safety of Canakinumab in a Large Cohort of Patients with Cryopyrin-Associated Periodic Syndrome: Results From the β-Confident Registry.
    Hoffman, H.
    Kuemmerle-Deschner, J. B.
    Hawkins, P.
    van der Poll, T.
    Walker, Ulrich A.
    Rauer, B.
    Nebesky, J. M.
    Tilson, H.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S78 - S78
  • [23] LONG-TERM SAFETY AND EFFECTIVENESS OF CANAKINUMAB IN CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES (CAPS)-4-YEARS DATA FROM THE RELIANCE REGISTRY
    Kuemmerle-Deschner, J. B.
    Kortus-Goetze, B.
    Schuetz, C.
    Oommen, P.
    Janda, A.
    Rech, J.
    Weller-Heinemann, F.
    Kallinich, T.
    Pankow, A.
    Horneff, G.
    Foeldvari, I.
    Wasiliew, P.
    Borte, M.
    Fiene, M.
    Meier, F.
    Krickau, T.
    Andreica, I.
    Weber-Arden, J.
    Blank, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 167 - 167
  • [24] LONG-TERM SAFETY AND EFFECTIVENESS OF CANAKINUMAB IN CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES (CAPS)-30-MONTH DATA FROM THE RELIANCE REGISTRY
    Kuemmerle-Deschner, J. B.
    Kortus-Goetze, B.
    Oommen, P.
    Janda, A.
    Rech, J.
    Kallinich, T.
    Weller-Heinemann, F.
    Horneff, G.
    Foeldvari, I.
    Schuetz, C.
    Borte, M.
    Braner, A.
    Weber-Arden, J.
    Blank, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 50 - 51
  • [25] Long-Term Safety and Effectiveness of Canakinumab in Patients with MKD/HIDS: Interim Analysis of the RELIANCE Registry
    Oommen, Prasad T.
    Kallinich, Tilmann
    Rech, Juergen
    Blank, Norbert
    Weber-Arden, Julia
    Kuemmerle-Deschner, Jasmin B.
    RHEUMATOLOGY AND THERAPY, 2025, 12 (01) : 137 - 155
  • [26] LONG-TERM EFFICACY AND SAFETY OF TOCILIZUMAB IN PATIENTS WITH REFRACTORY TAKAYASU ARTERITIS: FINAL RESULTS FROM THE TAKT STUDY
    Nakaoka, Yoshikazu
    Yamashita, Katsuhisa
    Okada, Norihiro
    Yamakido, Shinji
    RHEUMATOLOGY, 2019, 58
  • [27] Patients with Familial Mediterranean Fever (FMF) Under Canakinumab Treatment - Long-term Efficacy and Safety Interim Data of the RELIANCE Registry
    Henes, Joerg
    Kuemmerle-Deschner, Jasmin B.
    Krickau, Tobias
    Kallinich, Tilmann
    Dressler, Frank
    Horneff, Gerd
    Meier, Florian
    Foeldvari, Ivan
    Weller-Heinemann, Frank
    Kortus-Goetze, Birgit
    Hufnagel, Markus
    Rech, Juergen
    Oommen, Prasad T.
    Weber-Arden, Julia
    Blank, Norbert
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 257 - 259
  • [28] Influence of Canakinumab Dosing on Efficacy and Safety of Long-term Treatment in Patients with Familial Mediterranean Fever - Interim Analysis of the RELIANCE Registry
    Henes, Jorg
    Blank, Norbert
    Kallinich, Tilmann
    Dressler, Frank
    Horneff, Gerd
    Foeldvari, Ivan
    Hufnagel, Markus
    Kortus-Goetze, Birgit
    Weller-Heinemann, Frank
    Meier, Florian
    Weber-Arden, Julia
    Kuemmerle-Deschner, Jasmin
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 383 - 384
  • [29] Efficacy and Safety of Canakinumab in Patients with Systemic Juvenile Idiopathic Arthritis: Results from an Open-Label Long-Term Followup Study
    Brunner, Hermine L.
    Ruperto, Nicolino
    Quartier, Pierre
    Constantin, Tamas
    Alexeeva, Ekaterina
    Schneider, Rayfel
    Kone-Paut, Isabelle
    Schikler, Kenneth
    Marzan, Katherine
    Wulffraat, Nico
    Padeh, Shai
    Chasnyk, Vyacheslav
    Wouters, Carine
    Kuemmerle-Deschner, Jasmin B.
    Kallinich, Tilmann
    Lauwerys, Bernard
    Haddad, Elie
    Nasonov, Evgeny L.
    Trachana, Maria
    Vougiouka, Olga
    Leon, Karolynn
    Speziale, Antonio
    Lheritier, Karine
    Vritzali, Eleni
    Lovell, Daniel J.
    Martini, Alberto
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [30] Long-term Safety of Canakinumab in Patients with Autoinflammatory Periodic Fever Syndromes - Interim Analysis of the RELIANCE Registry
    Kuemmerle-Deschner, Jasmin
    Henes, Jorg
    Kortus-Goetze, Birgit
    Kallinich, Tilmann
    Oommen, Prasad T.
    Rech, Juergen
    Weller-Heinemann, Frank
    Horneff, Gerd
    Foeldvari, Ivan
    Janda, Ales
    Schuetz, Catharina
    Dressler, Frank
    Borte, Michael
    Hufnagel, Markus
    Braner, Axel
    Meier, Florian
    Fiene, Michael
    Weber-Arden, Julia
    Blank, Norbert
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 379 - 380